Investigation of Ribocyclib in Breast Cancer Treatment and Critical Appraisal of Trial Results

This week is the final episode of a joint mini-series with The Fellow On Call. We will be recapping the current treatment of localized ER+/HER-2- breast cancer and covering an oral abstract from the ASCO 2023 annual meeting,  the NATALEE Trial. We also cover some more statistics pearls that are important in oncology trials.